Henry Schein, Inc. (HSIC) Total Return CAGR:9.25%(TTM)
Over the latest trailing 12-month period, Henry Schein, Inc. (HSIC)'s total return cagr is +9.25%. The comparable SPY value is +24.27%. Year-to-date total return is +4.09%. Total return includes price appreciation and reinvested dividends.
Over longer horizons, Henry Schein, Inc.'s Total Return CAGR averages -0.44% over 3 years and 0.58% over 5 years. Total return includes dividends reinvested. The total return CAGR includes both price appreciation and dividends reinvested. This gives a more complete picture of Henry Schein, Inc.'s investment performance.
HSIC Total Return CAGR Chart
Henry Schein, Inc. (HSIC)
HSIC Quarterly Total Return (YoY)
Total Return Index growth vs the same quarter one year earlier, last 20 quarters.
HSIC Total Return CAGR History
| Year | Start Total Return | End Total Return | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2026 | 1101.31 | 1146.33 | +45.03 | +4.09% | +4.09% |
| 2025 | 1008.34 | 1101.31 | +92.97 | +9.22% | +9.22% |
| 2024 | 1103.20 | 1008.34 | -94.86 | -8.60% | -8.60% |
| 2023 | 1163.82 | 1103.20 | -60.62 | -5.21% | -5.21% |
| 2022 | 1129.72 | 1163.82 | +34.10 | +3.02% | +3.02% |
| 2021 | 974.25 | 1129.72 | +155.48 | +15.96% | +15.96% |
| 2020 | 972.21 | 974.25 | +2.04 | +0.21% | +0.21% |
| 2019 | 897.37 | 972.21 | +74.83 | +8.34% | +8.34% |
| 2018 | 798.63 | 897.37 | +98.74 | +12.36% | +12.36% |
| 2017 | 866.91 | 798.63 | -68.29 | -7.88% | -7.88% |
| 2016 | 903.94 | 866.91 | -37.03 | -4.10% | -4.10% |
| 2015 | 778.00 | 903.94 | +125.94 | +16.19% | +16.19% |
| 2014 | 652.92 | 778.00 | +125.09 | +19.16% | +19.16% |
| 2013 | 459.54 | 652.92 | +193.37 | +42.08% | +42.08% |
| 2012 | 368.17 | 459.54 | +91.37 | +24.82% | +24.82% |
| 2011 | 350.80 | 368.17 | +17.37 | +4.95% | +4.95% |
| 2010 | 300.57 | 350.80 | +50.23 | +16.71% | +16.71% |
| 2009 | 209.66 | 300.57 | +90.91 | +43.36% | +43.36% |
| 2008 | 350.86 | 209.66 | -141.20 | -40.24% | -40.24% |
| 2007 | 279.89 | 350.86 | +70.97 | +25.36% | +25.36% |
| 2006 | 249.37 | 279.89 | +30.51 | +12.24% | +12.24% |
| 2005 | 198.97 | 249.37 | +50.40 | +25.33% | +25.33% |
| 2004 | 193.34 | 198.97 | +5.63 | +2.91% | +2.91% |
| 2003 | 128.57 | 193.34 | +64.77 | +50.38% | +50.38% |
| 2002 | 105.80 | 128.57 | +22.77 | +21.52% | +21.52% |
| 2001 | 98.93 | 105.80 | +6.87 | +6.95% | +6.95% |
| 2000 | 38.04 | 98.93 | +60.89 | +160.09% | +160.09% |
| 1999 | 127.86 | 38.04 | -89.82 | -70.25% | -70.25% |
| 1998 | 100.00 | 127.86 | +27.86 | +27.86% | +27.86% |
| 1997 | 98.21 | 100.00 | +1.79 | +1.82% | +1.82% |
Quarterly Total Return: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 1,146 | +8.2% | +8.2% |
| Q1 2026 | 1,059 | -4.6% | +4.8% |
| Q4 2025 | 1,110 | +12.5% | +8.2% |
| Q3 2025 | 987 | -6.8% | -4.4% |
| Q2 2025 | 1,059 | +4.7% | +12.6% |
| Q1 2025 | 1,011 | -1.5% | -4.8% |
| Q4 2024 | 1,026 | -0.6% | -4.1% |
| Q3 2024 | 1,033 | +9.8% | -4.8% |
| Q2 2024 | 941 | -11.4% | -20.4% |
| Q1 2024 | 1,062 | -0.7% | -8.6% |
| Q4 2023 | 1,070 | -1.4% | -9.0% |
| Q3 2023 | 1,085 | -8.2% | +10.6% |
| Q2 2023 | 1,182 | +1.7% | +7.0% |
| Q1 2023 | 1,162 | -1.1% | -9.9% |
| Q4 2022 | 1,175 | +19.8% | +3.5% |
| Q3 2022 | 981 | -11.1% | -14.0% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Henry Schein, Inc.
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Andrea Albertini